Acute Effect of Aclidinium on Hyperinflation and Lung Volume Distribution in Severe COPD Patients
Phase of Trial: Phase IV
Latest Information Update: 15 May 2015
Price : $35 *
At a glance
- Drugs Aclidinium bromide (Primary) ; Glycopyrrolate (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 28 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 18 Sep 2014 Planned number of patients changed from 46 to 37 as per ClinicalTrials.gov record.
- 08 Jul 2014 New trial record